Drawing for Serial No. 79313274

USPTO serial 79313274

Serial No. 79313274

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KEELEY, ALISON REBECCA
Law office
TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Serial No. 79313274?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John C. Cain

John C. Cain Munck Wilson Mandala, LLP8945 Long Point Rd., Ste 120Houston, TX 77055UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Pharmacy retail services in the nature of retail pharmacy services and retail online ordering services in the field of pharmaceuticals; online retail store services in the field of pharmaceuticals and medicines; online retail store services in the field of pharmaceuticals and medicines; provision of an online marketplace for buyers and sellers of goods and servicesACTIVE—
044Medical advisory services; medical assistance consultancy provided by doctors and other specialized medical personnel; information services relating to health care; providing information in the field of medicine; provision of pharmaceutical information, namely, providing medical information about pharmaceuticals; medical information services provided via the Internet; pharmacy advisory services, namely, providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals; pharmacy dispensary services, namely, dispensing of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 13, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 13, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 11, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 23, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 23, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 13, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 13, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 21, 2022RFNTREFUSAL PROCESSED BY IB—
Mar 1, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 1, 2022RFRRREFUSAL PROCESSED BY MPU—
Feb 7, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 1, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2022RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jan 7, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 6, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2021DOCKASSIGNED TO EXAMINER—
Dec 5, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 9, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 9, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 9, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 25, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 21, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 17, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance